Results 261 to 270 of about 414,323 (331)

Ethical and Regulatory Considerations in the Clinical Translation of Pluripotent Stem Cell‐Derived NK Cell Therapies

Cell Proliferation, EarlyView.
Advancements in the generation of human pluripotent stem cell‐derived natural killer (PSC‐NK) cells have attracted considerable attention within the biomedical research community, offering a promising off‐the‐shelf technique for universal immune therapy.
Qianwen Chen, Jianwei Lv, Xinwei Xie, Hanlin Zhu, Zhenyu Xiao, Yaojin Peng   +5 more
wiley   +1 more source

Long-term outcomes and treatment patterns in Waldenström macroglobulinemia patients who discontinue Bruton tyrosine kinase inhibitor (BTKi) therapy

Blood Cancer Journal
Karan L. Chohan, Lorenzo Gensini, Sherif Seif, Xiaowen Sun, Lei Feng, Melody R. Becnel, Mahmoud M. Gaballa, Hans C. Lee, Oren Pasvolsky, Krina K. Patel, J. Christine Ye, Donna M. Weber, Robert Z. Orlowski, Sheeba K. Thomas   +13 more
doaj   +1 more source

Incidence and Clinical Outcomes of Vitamin D Status and Myeloma Bone Disease Among Patients With Newly Diagnosed Multiple Myeloma (MM) in a Tropical Country-Retrospective Cohort Study. [PDF]

Cancer Rep (Hoboken)
Lim CC, Tam WSW, De Mel WSP, Lang SP, Chng WJ, Soekojo CY, Song FF, Ooi MGM.   +7 more
europepmc   +1 more source

Adhesion of Immunoglobulins to Band3 Promotes Increased Erythrocyte Sedimentation Rate in Multiple Myeloma

Cell Proliferation, EarlyView.
Decreased sialic acid increases the adhesion of RBC membranes to immunoglobulins leading to an increased erythrocyte sedimentation rate (ESR). The increase in reactive oxygen species (ROS) damages the sialic acid glycosyl chains on the surface of RBC membrane proteins, causing the membrane proteins to be overexposed to the plasma environment due to the
Sicheng Bian, Jiangxia Cui, Xialin Zhang, Chongzhi Bai, Yanhong Tan, Zhuanghui Hao, Xingpeng Bu, Changxin Qu, Lili Sun, Leilei Lin, Qi Wang, Zhengrui Li, Xufeng Huang, Hengrui Liu, Ruo Wang, Yinghua Li, Hongwei Wang   +16 more
wiley   +1 more source

Targeting Siglec–sialic acid checkpoint to reverse immune dysfunction mediated by plasmacytoid dendritic cells in myeloma

Blood Advances
Arghya Ray, Leutz Buon, Xueping Wan, Ting Du, Yan Song, Sindhu C. Pillai, Md Abu Musa, Teng Fang, Minxing Wang, Kenneth C. Anderson   +9 more
doaj   +1 more source

Universal Use of Novel Oral Anticoagulant Prophylaxis in Myeloma Patients Undergoing IMiD-Based Therapy: Real-World Experience. [PDF]

J Clin Med
Mutlu YG, Uzunabdullah E, Yahya D, Ergün HB, Yiğit Kaya S, Maral S, Beköz HS, Kaynar L, Sevindik ÖG.   +8 more
europepmc   +1 more source

[Multiple myeloma with biclonal M protein: 6 cases report and literatures review].

, 2016
Qian Yang, J Hou, W M Chen, Xiao‐Jun Huang, Jin Lu   +4 more
openalex   +2 more sources

Targeting GPRC5D With CAR-T Cells in Relapse/Refractory Multiple Myeloma: Case Report and Literature Review. [PDF]

Case Rep Hematol
Yan S, Ming X, Wu J, Peng D, Zhou M, Xiao Y.   +5 more
europepmc   +1 more source

Clinical Application of¹⁸F-FDG-PET/CT in Multiple Myeloma

, 2012
Jeong‐Ah Kim
openalex   +1 more source

Comparative Effectiveness and Safety of PI‐Rd Triplets in Relapsed/Refractory Multiple Myeloma: INSIGHT‐MM Data Analysis

European Journal of Haematology, EarlyView.
Assessment of the comparative effectiveness and safety of three PI‐Rd triplets in relapsed/refractory multiple myeloma using data from the global, non‐interventional, observational INSIGHT‐MM study. ABSTRACT Objectives To assess the effectiveness/safety of three proteasome inhibitors (PIs), plus lenalidomide‐dexamethasone (Rd) triplet regimens, for the
Noemi Puig, Xavier Leleu, Hans C. Lee, Faith E. Davies, Roman Hájek, Vania Hungria, Michael A. Thompson, Gordon Cook, Jorge Vela Ojeda, Katja C. Weisel, Jesus G. Berdeja, Saad Z. Usmani, Argiris Symeonidis, Isabel Nascimento‐Ferreira, David Arthur, Lenka Mokrá, Kaili Ren, Dasha Cherepanov, Evangelos Terpos   +18 more
wiley   +1 more source